Joint research center founded at a world level of gene therapy.

Published: 2006-12-04 06:58:00

Updated: 2006-12-04 06:58:00

A joint research and development center will be founded by a Korean government supported research institute and an outstanding American bio venture company for a successful development of new gene therapy, cell therapy and new therapeutic proteins.

Korea Institute of Toxicology (KIT) (Chief director Han Sang-seop), a Korean government supported safety review institute, and ISIS pharmaceutica...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.